Table 1. Affected breast and delivered treatments prior to radiotherapy in the study sample (N = 37).

Parameter	Patient, n (%)
Side of the disease Right Left Bilateral	22 (59.5) 14 (37.8) 1 (2.7)
Surgery Mastectomy Sectorectomy	22 (59.5) 15 (40.5)
Chemotherapy AC Taxol AC + taxol FAC CMF	30 (81.1) 10 (33.3) 3 (10.0) 13 (43.3) 3 (10.0) 1 (3.3)
Hormone therapy Tamoxifen Other	23 (62.1) 14 (37.8) 9 (24.3)

AC: adriamycin + cyclophosphamide; FAC: fluorouracil + doxorubicin + cyclophosphamide; and CMF: cyclophosphamide + methotrexate + fluorouracil.